mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |